Basic Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jun 28, 2023; 29(24): 3770-3792
Published online Jun 28, 2023. doi: 10.3748/wjg.v29.i24.3770
Figure 8
Figure 8 Overexpressing ELL-associated factor 2 inhibits tumor-induced angiogenesis in RKO cells via transforming growth factor-β1 related pathway. A: Conditioned medium from RKO cells transfected with ELL-associated factor 2-overexpressed plasmids or treated with transforming growth factor-β1 recombinant protein was collected to perform tube formation assay; B and C: The migration ability of Human Umbilical Vein Endothelial Cells was analyzed by transwell migration assay (B) and wound healing assay (C). And the results were measured by ImageJ software. aP < 0.05, bP < 0.001. EAF2: ELL-associated factor 2; TGF-β1: Transforming growth factor-β1.